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The acute toxicity of the death camas (Zigadenus species) alkaloid
zygacine in mice, including the effect of methyllycaconitine
coadministration on zygacine toxicity1
K. D. Welch,2 K. E. Panter, D. R. Gardner, B. L. Stegelmeier, B. T. Green,
J. A. Pfister, and D. Cook
USDA-ARS Poisonous Plant Research Laboratory, Logan, UT 84341

ABSTRACT: Death camas (Zigadenus spp.) is a
common poisonous plant on foothill rangelands in western North America. The steroidal alkaloid zygacine is
believed to be the primary toxic component in death
camas. Poisonings on rangelands generally occur in the
spring when death camas is abundant, whereas other
more desirable forage species are limited in availability.
In most cases where livestock are poisoned by plants in
a range setting, there is more than one potential poisonous plant in that area. One common poisonous plant
that is often found growing simultaneously in the same
area as death camas is low larkspur (Delphinium nuttallianum). Consequently, the objectives of this study were
to conduct acute toxicity studies in mice and to determine if coadministration of low larkspur will exacerbate
the toxicity of death camas. We first characterized the
acute toxicity of zygacine in mice. The LD50 of zygacine
administered intravenously (i.v.) and orally was 2.0 ±
0.2 and 132 ± 21 mg/kg, respectively. The rate of elimination of zygacine from whole blood was determined to

be 0.06 ± 0.01/min, which corresponds to an elimination half-life of 13.0 ± 2.7 min. The i.v. LD50 of total
alkaloid extracts from a Utah and a Nevada collection
were 2.8 ± 0.8 and 2.2 ± 0.3 mg/kg, respectively. The
i.v. LD50 of methyllycaconitine (MLA), a major toxic
alkaloid in low larkspur, was 4.6 ± 0.5 mg/kg, whereas
the i.v. LD50 of a 1:1 mixture of MLA and zygacine was
2.9 ± 0.7 mg/kg. The clinical signs in mice treated with
this mixture were very similar to those of mice treated
with zygacine alone, including the time of onset and
death. These results suggest that there is an additive
effect of coadministering these 2 alkaloids i.v. in mice.
The results from this study increase knowledge and
understanding regarding the acute toxicity of death
camas. As combined intoxications are most likely common, this information will be useful in further developing management recommendations for ranchers and in
designing additional experiments to study the toxicity
of death camas to livestock.
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INTRODUCTION
There are many species of death camas (Zigadenus
spp.) located in North America (Burrows and Tyrl,
2001; Knight and Walter, 2001). Death camas is one
of the first species to grow in the spring. Poisonings
generally occur during the spring when death camas is
abundant, while other forage species have little growth.
Poisonings also occur on overgrazed ranges where better
quality forage has been depleted, or when management
errors result in hungry animals being moved into death
1
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camas-infested areas (Panter et al., 1987). Livestock
losses to death camas have been reported in numerous
species including cattle (Smith and Lewis, 1991; Collet
et al., 1996), horses (Morris, 1944), and sheep (Panter
et al., 1987), with the largest losses generally occurring
in sheep (Kingsbury, 1964). Sheep are primarily affected
because of their tendency to select forbs, particularly in
the early spring when there is little other plant growth.
Clinical signs of poisoning are similar for all animal
species studied (Panter et al., 2007). Zygacine (Figure
1) is often the most abundant alkaloid in death camas
and is consequently believed to be the primary toxic
component (Gilbertson, 1973; Majak et al., 1992).
In most cases in which livestock are poisoned by
plants in a range setting, there are multiple poisonous
plants in the area where the animals were poisoned. A
common poisonous plant found growing simultaneously

1650
Downloaded from jas.fass.org at University of Nebraska-Lincoln Libraries on May 4, 2011.

Acute toxicity of zygacine in mice

1651

Figure 1. Chemical structure of zygacine, the main alkaloid in Zigadenus paniculatus, and methyllycaconitine (MLA), a major toxic alkaloid
in low larkspur.

in the same area as death camas is low larkspur (Delphinium nuttallianum). Consequently, the objectives of
this study were to conduct preliminary acute toxicity
studies in mice and to determine if the coadministration of methyllycaconitine (MLA; Figure 1), one of the
major toxic alkaloids from low larkspur, exacerbates
the toxicity of zygacine. To accomplish this objective,
we characterized several different variables describing
the acute toxicity of zygacine in mice.

MATERIALS AND METHODS
All procedures were conducted under veterinary supervision and were approved by the Utah State University Institutional Animal Care and Use Committee.

Alkaloid Preparation
Zygacine and death camas total alkaloid extracts were
extracted from Zigadenus paniculatus that was collected in the late pod stage near Logan, Utah (41°46.098′
N, 111°46.688′ W, elevation 1,539 m). A crude alkaloid extract was also isolated from Z. paniculatus that
was collected in the late pod stage near Tuscarora, Nevada (41°38.167′ N, 116°21.947′ W, elevation 1,586 m).
Crude alkaloids were isolated from dry ground plant
material (50 g) by extraction with 1 L of methanol for
24 h. The mixture was filtered and the methanol extract was concentrated by removal of the methanol using rotary evaporation under reduced pressure at 45°C.
The residue was then rinsed multiple times with 25 mL

of 1% sulfuric acid and 25 mL of chloroform for a total
volume of 250 mL, which was placed into a separatory funnel. The chloroform portion was drained and
the acid solution was extracted 2 additional times with
100 mL of chloroform. The acid solution was cooled
in an ice bath and the pH was adjusted to ≈10 by
the slow addition of 28% ammonium hydroxide. The
aqueous base solution was then placed into a separatory funnel and extracted 3 times with 100 mL of chloroform. Chloroform extracts were combined and dried
over anhydrous sodium sulfate, filtered, and the solvent
removed under reduced pressure by rotary evaporation.
The dried crude alkaloid residue was scraped from the
round bottom flask, weighed, and stored at −20°C. Zygacine was isolated and purified from the crude alkaloid
residue by flash chromatography on silica gel (5 × 11
cm column) eluting with 2%-increase step gradients of
chloroform/methanol/ammonium hydroxide (98/2/0.1
to 90/10/0.1) and then crystallization from hexane/acetone. The percentage of zygacine in each sample was
determined by HPLC-mass spectrometry (MS) analysis on a weight basis of the crude alkaloid extract.
The MLA used in this study was extracted from Delphinium barbeyi following previously published methods (Pelletier et al., 1981, 1989; Manners et al., 1991);
MLA is identical in low larkspur. The purified alkaloids
and alkaloid extracts were suspended in PBS solution.
The pH of each solution was reduced with 1 N HCl
to achieve solubility. Ammonium hydroxide (28%) was
then added to the solutions to increase the pH above
6.0. The solutions were stored in sterile injection vials
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at 4°C until use. No adverse effects were seen after intravenous (i.v.) injections in mice (0.05 to 0.2 mL) of a
PBS solution at pH 6.0.

Animals
Male Swiss Webster mice were purchased from Simonson Laboratories Inc. (Gilroy, CA). Mice were acclimated for 3 to 4 d with free access to food [Harlan
Teklad rodent diet (w) 8604, Harlan Teklad, Madison,
WI] and water before beginning experiments.

Median Lethal Dose Determination
The LD50 of each solution was determined using male
Swiss Webster mice weighing 25 ± 3 g. For i.v. injections, solutions ranging between 0.05 and 0.2 mL were
injected via the tail vein. For oral administration, solutions ranging between 0.09 and 0.45 mL were administered via a 20-gauge, 3.8-cm oral-gavage needle. Mice
were observed for clinical effects and mortality. The
LD50 of the solutions were determined using a modified
up-and-down method (Bruce, 1987). Using this method
for acute toxicity testing, animals are dosed one at a
time. If the first animal survives, then the next animal receives a larger dose, whereas if the first animal
dies the next animal receives a smaller dose. The dose
for each successive animal is increased or decreased
depending upon the outcome for the previous animal.
This causes the doses to be rapidly adjusted toward
the LD50 and then be maintained in the region of the
LD50. This method is preferred because fewer animals
are required; however, it results in unbalanced numbers
in each group. The LD50 values were calculated using
SAS Proc Probit in a logistic regression (SAS Inst. Inc.,
Cary, NC).

Toxicokinetic Analyses
For toxicokinetic studies, 40 male Swiss Webster
mice weighing 21 ± 1 g were randomly divided into
8 groups of 5 mice each, to obtain samples at 8 time
points after injection (0, 1, 2, 5, 10, 15, 30, and 60 min).
Mice were dosed via the tail vein with 50% of the i.v.
LD50 dose (1.0 mg/kg), as determined in the LD50 studies. This dose produced clinical signs but no mortality.
Mice were killed by CO2 asphyxiation followed by cervical dislocation. Whole blood (0.5 mL) was collected by
cardiac puncture and frozen at −20°C until analyzed.

Sample Extractions
Whole blood samples were thawed, vortexed, and
then centrifuged at 16,000 × g at room temperature
for 5 min. A 200-µL aliquot was taken and placed in
a 2-mL eppendorf tube. To each sample was added an
equal volume of acetonitrile (200 µL). Samples were
vortexed and centrifuged at 16,000 × g at room temperature for 5 min. A 200-µL aliquot was transferred

to HPLC autosample vial and samples again centrifuged 2,500 × g at room temperature for 5 min before analysis. Standards were prepared from a stock
solution of purified zygacine (0.5 mg/mL, chloroform)
at 1,000, 500, 250, 125, 62.5, and 31 ng/mL by serial
dilutions using 50% acetonitrile in water. Samples and
standards were analyzed by HPLC-tandem mass spectrometry (MS/MS) using a Thermo Finnigan LCQ
Advantage Max MS coupled with a Thermo Finnigan
Surveyor autosampler, MS solvent pump, and electrospray ion source (Thermo Finnigan, San Jose, CA).
The HPLC column was a Betasil C18 column (100 ×
2.1 mm, Thermo Fisher Scientific Inc., Waltham, MA)
with a guard column (10 × 2.1 mm) of equivalent phase
eluted with a gradient mixture of methanol/20 mM ammonium acetate at a flow rate of 0.300 mL/min. Solvent gradient: 10% methanol (0 to 2 min); 10 to 40%
methanol (2 to 3 min); 40 to 80% methanol (3 to 10
min); isocratic 80% methanol (10 to 14 min). Injection
volume was 5 µL. Zygacine was detected from the reconstructed ion chromatograms (m/z = 518) from the
m/z 536 to 518 MS/MS transition and calibration and
quantitation based on peak area measurements. Based
on sample signal-to-noise ratio of 3 and 10, the limit of
detection and quantitation were estimated to be 4 and
10 ng/mL, respectively, in the blood. Identification of
the zygacine was based on comparison of retention time
and MS/MS fragmentation pattern. The interassay CV
for this method is approximately 11%.

Analysis and Statistics
Statistical comparisons of toxicokinetic profiles between 3 or more groups were performed using ANOVA
with a posthoc test of significance between individual
groups using SigmaStat (SPSS Inc., Richmond, CA).
Statistical comparisons of toxicokinetic profiles between
2 groups were performed using a 2-tailed, unpaired Student’s t-test. The alkaloid concentrations were plotted.
Kinetic profiles were analyzed using standard pharmacokinetic software (PK Solutions 2.0 for Noncompartmental Pharmacokinetic Data Analysis, Summit
Research Services, Montrose, CO). A curve-stripping
procedure was used to determine the basic pharmacokinetic parameters of half-life and rate for the elimination phase from blood of the zygacine concentration
curve. The following variables were determined: t½,
kelim, Vd, Cl, and AUC, where t½ is the elimination
half-life, kelim is the elimination rate, Vd is the volume
of distribution, and Cl is the clearance rate in blood,
and AUC is the area under the curve. The trapezoidal
method was used to determine the AUC of a concentration vs. time graph.

RESULTS
Chromatograms (HPLC-MS) of alkaloid extracts
from 2 death camas (Z. paniculatus) collections used
for this study are shown in Figure 2. Zygacine (reten-
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Figure 2. Reconstructed base peak ion chromatograms from HPLC-tandem mass spectrometry (MS/MS) analysis of total alkaloid extracts
from 2 Zigadenus paniculatus populations. Identification of zygacine (retention time = 7.2 min) was based on comparison of retention time and
MS/MS fragmentation pattern with standard. Unidentified peaks are presumed to be other minor alkaloids in the plant based on the isolation
procedure for the analyzed extract. The percentage of zygacine in each sample was determined by HPLC-mass spectrometry analysis on a weight
basis of the crude alkaloid extract.

tion time = 7.2 min) was the major alkaloid in both extracts. In the Utah collection, zygacine was 58% of the
total crude alkaloid residue. For the Nevada collection,
zygacine was 41% of the total crude alkaloids.
The acute toxicity of zygacine was compared with
the total alkaloid extracts from the 2 death camas collections (Figure 3 and Table 1). The i.v. LD50 of zygacine was 2.0 ± 0.2 mg/kg, whereas the i.v. LD50 of the
total alkaloid extracts were 2.8 ± 0.8 and 2.2 ± 0.3 mg/
kg for the Utah and Nevada collections, respectively. In
addition to determining the LD50 of zygacine administered i.v., we also determined the LD50 of zygacine
administered orally to mice (Figure 4 and Table 1). The
oral LD50 of zygacine in mice was 132 ± 21 mg/kg.
Clinical signs of poisoning in mice treated i.v. with
a lethal dose of zygacine or total alkaloid extract from
death camas were as follows: within seconds of injection, mice were reluctant to move. Within 1 min, mice
developed chewing movements, excessive facial grooming, and increased aggression to neighboring animals.
As these symptoms became more severe, poisoned mice
developed muscle tremors and spastic involuntary muscular contractions seen as marked extension of the head
and neck as well as tail flicking and signaling. These
involuntary tremors became more severe until the mice
were fatigued and could not move voluntarily. Lethally
poisoned mice struggled for breath, which was seen as
spasmodic jumps and shaking. These animals quickly
became cyanotic and died. Typically, lethally poisoned
animals died within 2 min of treatment. Animals that
did not die recovered within 20 min; however, the mice
remained hypersensitive to any stimulation for 1 to 2 h
after treatment. The clinical signs of poisoning in mice

treated orally were very similar to those observed in
the i.v. dosed mice, except for a delay (20 to 30 min) in
the onset, and they also remained hypersensitive for a
longer duration (2 to 4 h).
Five mice were dosed i.v. with zygacine at 1.0 mg/
kg for each time point of sample collection. Blood was
collected from the mice, and zygacine was extracted
from whole blood and analyzed by HPLC-MS/MS (Figure 5). The elimination kinetic profile of zygacine from

Figure 3. Comparison of the acute toxicity of zygacine vs. a total
alkaloid extract from a Utah (UT) and a Nevada (NV) death camas
population. The data represent the LD50 of zygacine and total alkaloid extracts from 2 different collections of death camas (Zigadenus
paniculatus). Results represent the mean ± SD of 24 to 31 mice per
group. Letters (a–c) above bars designate groups for which there is a
difference, P < 0.05.

Downloaded from jas.fass.org at University of Nebraska-Lincoln Libraries on May 4, 2011.

1654

Welch et al.

Table 1. Median lethal dose, BW, and injection volume for 2 death camas (Zigadenus
paniculatus) extracts (total alkaloids) from Utah and Nevada, purified zygacine (intravenous and oral routes), purified methyllycaconitine (MLA), and a combination of
zygacine plus MLA1
Sample
size

Compound
Alkaloid extract, Utah
Alkaloid extract, Nevada
Zygacine
Zygacine, oral
MLA
Zygacine + MLA (1:1)

34
24
31
38
28
39

LD50,2 mg/kg
2.8
2.2
2.0
132
4.6
2.9

±
±
±
±
±
±

0.8
0.3
0.2
21
0.5
0.7

BW,3 g
22.9
29.8
23.9
26.4
23.0
23.5

±
±
±
±
±
±

1.6
2.0
1.9
3.2
1.2
1.4

Injection
volume,4 mL
0.16
0.16
0.13
0.27
0.14
0.09

±
±
±
±
±
±

0.04
0.04
0.05
0.10
0.02
0.02

1

Material was administered to mice intravenously unless otherwise indicated.
Results represent the mean ± SD of the LD50.
3
Results represent the mean ± SD of the animal BW.
4
Results represent the mean ± SD of the injection volume.
2

whole blood was characterized (Figure 6). The rate of
elimination of zygacine from whole blood was determined to be 0.06 ± 0.01/min, which corresponded to a
t½ of 13.0 ± 2.7 min. Consequently, in the mouse 99%
of the zygacine is eliminated from blood in approximately 91 min. The AUC was calculated to be 5.6 ± 1.0
µg/mL × min. The volume of distribution for zygacine
was 74.8 ± 20.6 mL, and the clearance rate was 4.0 ±
0.6 mL/min.
A main objective of this study was to determine if
coadministration of a toxic larkspur alkaloid would exacerbate the toxicity of zygacine. The LD50 values of
MLA and zygacine were 4.6 ± 0.5 and 2.0 ± 0.2 mg/
kg, respectively (Figure 7 and Table 1). In comparison,
the LD50 of a 1:1 mixture of MLA to zygacine was 2.9
± 0.7 mg/kg. The LD50 value for the mixture is almost
halfway between the LD50 values for the individual
compounds, suggesting that both alkaloids contribute
to the toxicity. Also, the mice treated with this mixture showed clinical signs very similar to those of mice
treated with zygacine alone, including time to death.
Similar results were observed when the toxicity of a 1:1
mixture of a death camas total alkaloid extract and a
low larkspur total alkaloid extract was compared with
the toxicities of the individual total alkaloid extracts
(data not shown).

synergistic, or antagonistic effect. There is potential
that the toxicosis elicited by one toxin could potentiate the toxicity of another toxin such that a sublethal
dose of each toxin, when combined, could produce a lethal result (Davis and Hatoum, 1980; Huff et al., 1988;
Welch et al., 2008; Hellmann et al., 2010).
One of the objectives of this study was to determine
if the coadministration of MLA, the major toxic alkaloid in low larkspur (Bai et al., 1994; Gardner and
Pfister, 2009), would exacerbate the toxicity of zygacine, the major toxic alkaloid in death camas. Death
camas and low larkspur are commonly found in the
same geographical locations and growing at the same
time (Burrows and Tyrl, 2001). Thus, foraging animals
could potentially consume both plants. In fact, we have
repeatedly seen evidence that livestock have consumed
both plants (K. D. Welch, unpublished observations).
Additionally, both zygacine and MLA have been identified in the blood and gastrointestinal contents from
poisoned animals (D. R. Gardner, personal observations). Much information is known about the toxicity

DISCUSSION
In most rangeland settings, there are multiple poisonous plants growing in the same area (Kingsbury, 1964;
Burrows and Tyrl, 2001). Consequently, animals are exposed to numerous poisons and not just a single toxin.
For many of the poisonous plants, basic toxicological
information is available such as the LD50, the mechanism of action, and the clinical signs associated with
their toxicoses (Burrows and Tyrl, 2001; Burrows et al.,
2004; Panter et al., 2007). However, very rarely is there
information available on the effects of animals consuming combinations of these poisonous plants. Thus, questions remain as to whether consumption of multiple
poisonous plants by an animal could have an additive,

Figure 4. Comparison of the intravenous LD50 vs. the oral LD50 of
zygacine. The data represent the LD50 of zygacine dosed intravenously
(IV) and orally. Results represent the mean ± SD of 31 to 38 mice per
group; *P < 0.05 as compared with the IV-dosed group.
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Figure 5. Reconstructed ion chromatogram (m/z = 518) from HPLC-tandem mass spectrometry (MS/MS) analysis of whole blood showing
the detection of zygacine (upper panel) and the corresponding MS/MS spectrum of zygacine (fragmentation of parent ion m/z 536) below.

of larkspur (Pfister et al., 1999; Green et al., 2009).
The LD50 for i.v. route of administration in mice is
approximately 4.5 mg/kg (Pfister et al., 1999; Panter
et al., 2002; Welch et al., 2008, 2009). The mechanism
of action is via the competitive inhibition of nicotinic
acetylcholine receptors, causing muscle weakness and
death due to respiratory failure (Benn and Jacyno,
1983; Dobelis et al., 1999). Less is known about the
toxicity of death camas (Panter et al., 1987; Burrows
et al., 2004; Panter et al., 2007). The toxic alkaloids in
death camas are steroidal alkaloids of the same class
as those in Veratrum species (Kupchan, 1959; Burrows
and Tyrl, 2001), which are suggested to alter sodium
transport in the cardiac nerves (Burrows et al., 2004).

The clinical signs of animals poisoned by death camas
include ataxia, muscular weakness, trembling, incoordination, discharge of frothy saliva from the mouth and
nose, vomition, dyspnea, collapse, and death (Panter
et al., 1987). Based on the clinical signs observed, the
toxic alkaloids in death camas likely affect more than
just the sodium channels in the cardiac nerves. However, because the toxins from both plants appear to be
neurotoxins, there is a possibility that the inhibition of
nicotinic acetylcholine receptors by larkspur alkaloids
could exacerbate the toxicosis caused by death camas
alkaloids.
Before performing these types of experiments in
larger livestock species, we first used a rodent mod-

Figure 6. Kinetic profile of zygacine in whole blood. Data represent the whole blood concentration of zygacine from mice dosed
intravenously with 1.0 mg/kg of zygacine. Results represent the mean
± SD of the concentration of zygacine in whole blood for 5 mice at
each time point.

Figure 7. Comparison of the acute toxicity of zygacine, methyllycaconitine (MLA), as well as a 1:1 mixture of zygacine and MLA.
The data represent the LD50 of zygacine, MLA, and a 1:1 mixture of
zygacine and MLA. Results represent the mean ± SD of 28 to 39 mice
per group. Letters (a–c) above bars designate groups for which there
is a difference, P < 0.05.
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el. We were unable to find a published LD50 value for
death camas alkaloids, especially zygacine. Therefore,
we characterized the acute toxicity of a death camas
extract from Z. paniculatus, or foothill death camas,
and zygacine, the major alkaloid in Z. paniculatus. The
LD50 for zygacine (2.0 mg/kg) was different than the
alkaloid extract from the Utah collection (2.8 mg/kg)
but not the alkaloid extract from the Nevada collection
(2.2 mg/kg). There was also a difference between the
LD50 of the alkaloid extract from the Utah collection
and the alkaloid extract from the Nevada collection.
Not all of the alkaloids in death camas have been indentified, nor have their toxicities been determined. The
alkaloid extract from the Utah collection contained a
greater percentage of zygacine than the alkaloid extract
from the Nevada collection, and yet the alkaloid extract
from the Nevada collection was more toxic. Additionally, the alkaloid extract from the Utah collection was
58% zygacine, yet the LD50 was only 1.4 times that of
zygacine alone. Both of these observations are highly
suggestive that other components of the extracts also
contributed to the toxicity. Consequently, the results
from this study suggest that zygacine is the major alkaloid in Z. paniculatus and that additional alkaloids in
death camas contribute to its toxicity. Further studies
are needed to identify and characterize the other toxic
alkaloids in death camas.
Determination of an LD50 value for a compound administered i.v. is valuable because it provides basic
information regarding the toxicity of the parent compound without conflicting factors such as the rate of
absorption or potential metabolic changes that can occur before the compound reaches general circulation
(Klaassen, 2001; Eaton and Gilbert, 2008). However,
i.v. administration is not a real-world scenario for toxins from a poisonous plant. Therefore, we also determined the LD50 value for zygacine administered orally.
The LD50 value for orally administered zygacine was
approximately 132 mg/kg. This is over 60 times less
toxic than i.v. route. It is common for the toxicity of
a compound to be less toxic when administered orally
vs. i.v. (Lehmann-McKeeman, 2008). There are several
potential explanations for the difference, with the primary reason being a reduced rate, or overall amount, of
absorption from the gastrointestinal tract (Shargel and
Yu, 1993). The rate at which a compound is absorbed
will influence the toxicity of a compound (LehmannMcKeeman, 2008; Shen, 2008). Conversely, with an i.v.
administration the entire dose is immediately bioavailable and thus potentially more toxic, if the parent compound is the active toxin (Shargel and Yu, 1993). Similarly, when a compound is administered orally, much of
the dosed compound can be metabolized to a less toxic
compound en route to general circulation, especially in
the liver (Eaton and Gilbert, 2008), rumen microflora
(Weimer, 1998), and rumen wall (Watkins et al., 1987;
Smith, 1992).
In addition to knowing the LD50 value for zygacine,
it is also valuable to know the rate at which zygacine

is eliminated from the body, as well as the AUC. We
have presumed that elimination from the blood results
in elimination from the body and not redistribution
within tissues. The kinetic variable AUC provides a
general indication as to the bioavailability of a compound, summarily depicting the absorption, distribution, and elimination of the compound (Shargel and
Yu, 1993). The rate of elimination is valuable in both
i.v. and orally dosed animals because it dictates how
long the toxin will remain in the body (Shargel and Yu,
1993; Shen, 2008). In this study, we found the AUC for
zygacine to be approximately 5,550 ng·mL−1 × min,
and the t½ for zygacine was 0.06/min, which indicates
that the t½ from blood was approximately 13 min. We
calculated the Vd to be approximately 75 mL, which
indicates that zygacine is widely distributed to the peripheral tissues. However, the clearance rate of 4 mL/
min may indicate that zygacine is either rapidly cleared
from the blood or is rapidly metabolized. These kinetic
variables are useful in evaluating relative risk and to
enhance current management recommendations for animals grazing in death camas-infested rangelands.
A t½ of 13 min indicates that 91 min after exposure over 99.2% of the zygacine is eliminated from the
blood. However, we observed that mice dosed with zygacine in this study remained hypersensitive beyond 91
min. There are several possible explanations for this
discrepancy. One explanation is that the toxic alkaloids
in death camas bind to a receptor such that residual
amounts of alkaloid, below the limit of detection in
blood, would maintain the mice in a state of hypersensitivity. Another explanation is that the active compound that binds to the receptor is a metabolite and
consequently not accounted for in the kinetic analyses
of the parent compound.
The results from this study indicate that both MLA
and zygacine are very toxic. The LD50 value for a 1:1
mixture of MLA and zygacine (2.9 mg/kg) was different from the LD50 value of zygacine alone and MLA
alone. The i.v. LD50 value of the mixture is almost halfway between the individual values of each compound.
However, in essence, the LD50 value for the mixture
corresponds to a value of 1.45 mg/kg for each alkaloid,
which is significantly less than the LD50 for each individual compound. Consequently, these results suggest
that the toxicity is additive when combining these 2
toxins, at least for an acute i.v. toxicity study in mice.
Perhaps in a ruminant animal that is dosed orally, a
different interaction between the 2 compounds could
occur, including a synergistic interaction. Oral dosing
in a ruminant animal to compare individual and combined effects of death camas and larkspur needs to be
performed before any management recommendations
can be made concerning the risk for animals grazing on
rangelands that contain both poisonous plants.
In summary, the results from this study demonstrate
that zygacine is a very toxic compound with an i.v.
LD50 value of 2 mg/kg in mice. We also demonstrated
that zygacine is the major alkaloid in Z. paniculatus
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and that zygacine accounts for the majority of the toxicity of a total alkaloid extract from death camas. In
addition, we report the t½ of zygacine in mice to be
approximately 13 min. Finally, the coadministration of
death camas and low larkspur alkaloids has an additive
effect, resulting in enhanced toxicity. The results from
this study provide an increased knowledge and understanding regarding the acute toxicity of death camas.
This information will be useful in further developing
livestock management recommendations for ranchers
and in designing additional experiments to study the
toxicity of death camas in livestock species.
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